US drugmaker Eli Lilly and Company announced that it was slashing prices of its most commonly-prescribed insulins by 70 percent. Lilly said it would cut the price of its non-branded insulin to $25 a vial from May 1. It will also cut the price of Humalog, the company’s most commonly-prescribed insulin and Humalin injections by 70 percent towards the end of the year.
You May Also Like
Two-day pharma and healthcare expo kickstarts
Lahore: Pak Pharma and Healthcare expo in collaboration with the Pakistan Pharmaceutical…
- Alina Hashmi
- February 16, 2023
Punjab changes admission policy for medical, dental colleges
The Punjab education authorities have changed the admission policy for the government…
- Hafsa Mustafa
- October 2, 2023
Trio wins Nobel Chemistry Prize for quantum dots
French-born Moungi Bawendi, Louis Brus of the United States and Russian-born Alexei…
- Hafsa Mustafa
- October 4, 2023
Pakistan records 150 fresh Covid-19 cases
Pakistan has registered one death in the last 24 hours by Covid-19,…
- Hafsa Mustafa
- March 24, 2023